Healthcare · Drug Manufacturers Specialty Generic · NYSE
Elanco Animal Health Incorporated (ELAN) is a Healthcare company in the Drug Manufacturers Specialty Generic industry. It has a market capitalization of $11.45B, a trailing price-to-earnings ratio of 21.6 and a free-cash-flow yield of 2.5%. Over the most recent reported fiscal year, revenue grew 6.2% and free cash flow per share fell 27.8%.